NxStage Medical, Inc.  

(Public, NASDAQ:NXTM)   Watch this stock  
Find more results for NXTM
+0.05 (0.31%)
May 27 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 16.15 - 16.42
52 week 11.50 - 19.63
Open 16.26
Vol / Avg. 343,691.00/519,273.00
Mkt cap 1.03B
P/E     -
Div/yield     -
EPS -0.39
Shares 63.21M
Beta 0.41
Inst. own 96%
Aug 5, 2015
Q2 2015 NxStage Medical Inc Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Jun 9, 2015
NxStage Medical Inc at William Blair Annual Growth Stock Conference - 11:50AM EDT - Add to calendar
Jun 1, 2015
NxStage Medical Inc at Jefferies Global Healthcare Conference - 11:30AM EDT - Add to calendar
May 21, 2015
NxStage Medical Inc Annual Shareholders Meeting
May 7, 2015
NxStage Medical Inc at Deutsche Bank Health Care Conference
May 6, 2015
Q1 2015 NxStage Medical Inc Earnings Release
May 6, 2015
Q1 2015 NxStage Medical Inc Earnings Call - Webcast
Mar 11, 2015
NxStage Medical Inc at Barclays Healthcare Conference - Webcast
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '15) 2014
Net profit margin -7.38% -8.06%
Operating margin -7.02% -7.36%
EBITD margin - 1.83%
Return on average assets -7.66% -7.89%
Return on average equity -11.95% -12.45%
Employees 3,400 -
CDP Score - -


350 Merrimack St
LAWRENCE, MA 01843-1748
United States - Map
+1-978-6874700 (Phone)
+1-302-6555049 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


NxStage Medical, Inc. (NxStage)is a medical device company that develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. The Company’s primary product is the NxStage System One (System One). It also sells needles and blood tubing sets primarily to dialysis clinics for the treatment of end-stage renal disease (ESRD). The Company operates in two segments: System One and In-Center. It distributes its products in three markets: home, critical care and in-center. In the System One segment it sells and rents the System One, PureFlow SL equipment and disposable products in the home and critical care markets. In the In-Center segment, it sells of blood tubing sets and needles for hemodialysis at dialysis centers and needles for apheresis. The Company’s products include the NxStage System One, Streamline Blood Tubing Sets and AV Fistula and Apheresis Needles.

Officers and directors

Robert G. Funari Independent Chairman of the Board
Age: 67
Bio & Compensation  - Reuters
Joseph E. Turk Jr. President
Age: 47
Bio & Compensation  - Reuters
Jeffrey H. Burbank Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Matthew W. Towse CPA, Chief Financial Officer, Senior Vice President
Age: 52
Bio & Compensation  - Reuters
Robert S. Brown CPA, President of NxStage Kidney Care
Age: 56
Bio & Compensation  - Reuters
Winifred L. Swan J.D. Senior Vice President, General Counsel
Age: 50
Bio & Compensation  - Reuters
Daniel A. Giannini CPA, Independent Director
Age: 65
Bio & Compensation  - Reuters
Earl R. Lewis Independent Director
Age: 71
Bio & Compensation  - Reuters
Jean K. Mixer Independent Director
Age: 48
Bio & Compensation  - Reuters
Craig W. Moore Independent Director
Age: 69
Bio & Compensation  - Reuters